GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) » Definitions » Cyclically Adjusted Book per Share

Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Cyclically Adjusted Book per Share : HK$2.68 (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's adjusted book value per share for the three months ended in Sep. 2024 was HK$9.110. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is HK$2.68 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Shenzhen Hepalink Pharmaceutical Group Co's average Cyclically Adjusted Book Growth Rate was 1.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shenzhen Hepalink Pharmaceutical Group Co was 3.70% per year. The lowest was 2.00% per year. And the median was 2.20% per year.

As of today (2024-12-15), Shenzhen Hepalink Pharmaceutical Group Co's current stock price is HK$4.11. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was HK$2.68. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is 1.53.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 4.29. The lowest was 1.05. And the median was 2.40.


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 4.70 3.32 3.05 2.21

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.41 2.21 2.43 2.74 2.68

Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio falls into.



Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shenzhen Hepalink Pharmaceutical Group Co's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book= Book Value per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=9.11/115.7848*115.7848
=9.110

Current CPI (Sep. 2024) = 115.7848.

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data

Book Value per Share CPI Adj_Book
201412 8.093 99.000 9.465
201503 8.281 99.900 9.598
201506 8.185 99.500 9.525
201509 7.887 100.500 9.087
201512 8.184 100.600 9.419
201603 7.947 102.200 9.003
201606 7.416 101.400 8.468
201609 7.446 102.400 8.419
201612 7.166 102.600 8.087
201703 7.224 103.200 8.105
201706 6.908 103.100 7.758
201709 7.185 104.100 7.991
201712 7.389 104.500 8.187
201803 7.456 105.300 8.198
201806 7.429 104.900 8.200
201809 5.349 106.600 5.810
201812 5.555 106.500 6.039
201903 6.202 107.700 6.668
201906 5.975 107.700 6.424
201909 6.036 109.800 6.365
201912 6.556 111.200 6.826
202003 6.793 112.300 7.004
202006 6.803 110.400 7.135
202009 8.725 111.700 9.044
202012 9.347 111.500 9.706
202103 9.526 112.662 9.790
202106 9.571 111.769 9.915
202109 9.615 112.215 9.921
202112 9.523 113.108 9.748
202203 9.782 114.335 9.906
202206 9.614 114.558 9.717
202209 9.420 115.339 9.456
202212 9.371 115.116 9.425
202303 9.607 115.116 9.663
202306 9.242 114.558 9.341
202309 9.070 115.339 9.105
202312 8.880 114.781 8.958
202403 8.931 115.227 8.974
202406 8.903 114.781 8.981
202409 9.110 115.785 9.110

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Shenzhen Hepalink Pharmaceutical Group Co  (HKSE:09989) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.11/2.68
=1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 4.29. The lowest was 1.05. And the median was 2.40.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Hepalink Pharmaceutical Group Co Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business, and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from USA and Europe.
Executives
Hong Ze Jun 2101 Beneficial owner
Orbimed Capital Llc 2102 Investment manager
Morgan Stanley & Co. International Plc 2105 Underwriter
Morgan Stanley International Holdings Inc. 2201 Interest of corporation controlled by you
Morgan Stanley International Limited 2201 Interest of corporation controlled by you
Morgan Stanley Investments (uk) 2201 Interest of corporation controlled by you
Avict Global Holdings Limited 2101 Beneficial owner
Worldwide Healthcare Trust Plc 2101 Beneficial owner

Shenzhen Hepalink Pharmaceutical Group Co Headlines

No Headlines